Article
Metabolic reprogramming and disease progression in cancer patients.
Biochimica et biophysica acta. Molecular basis of disease - 1 May 2020
Torresano Laura, Nuevo-Tapioles Cristina, Santacatterina Fulvio, Cuezva José M
Abstract excerpt
Genomics has contributed to the treatment of a fraction of cancer patients. However, there is a need to profile the proteins that define the phenotype of cancer and its pathogenesis. The reprogramming of metabolism is a major trait of the cancer phenotype with great potential for prognosis and targeted therapy. This review overviews the major changes reported in the steady-state levels of proteins of metabolism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
